← Leaderboards
Stanislaw F Wnuk
Florida International University
$1,680,017
Attributed
$1,680,017
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225.6K · FY2005–11$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,680,017 · 2
By mechanism
S06$861,792 · 1
SC1$818,225 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Nucleoside Analog”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Robert Turner Schooley · University Of Colorado Denver$49,550,018
- Jeffrey S Glenn · Stanford University$19,514,752
- Ruth Martha Greenblatt · University Of California San Francisco$19,382,210
- Vern L. Schramm · Yeshiva University$18,631,228
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Research focus
Nucleoside AnalogHomocysteineEnzyme InhibitorsAdenosineHydrolaseRibonucleotide ReductaseActive SitesOxidoreductase InhibitorNucleic Acid Chemical SynthesisEnzyme MechanismElectron Spin Resonance SpectroscopyAffectHomocystineBaseGenerationsEnzymesEnzyme Inhibitor DrugsCancer CellCell ProliferationBiomimeticsDisulfidesBiological TestingAnalogBiochemical
Grant awards (13)
Nucleoside and Carbohydrate-based Enzyme Inhibitors$215,325
SC1 · FY2011 · CA · contact PI
Nucleoside and Carbohydrate-based Enzyme Inhibitors$217,500
SC1 · FY2010 · CA · contact PI
Nucleoside and Carbohydrate-based Enzyme Inhibitors$216,125
SC1 · FY2009 · CA · contact PI
Nucleoside and Carbohydrate-based Enzyme Inhibitors$169,275
SC1 · FY2008 · CA · contact PI
Nucleoside-based Enzyme Inhibitors$225,614
S06 · FY2007 · GM · contact PI
Nucleoside-based Enzyme Inhibitors$88,751
S06 · FY2006 · GM · contact PI
Nucleoside-based Enzyme Inhibitors$90,225
S06 · FY2005 · GM
Nucleoside-based Enzyme Inhibitors$88,172
S06 · FY2004 · GM
Nucleoside Based Enzyme Inhibitors$73,806
S06 · FY2002 · GM
Nucleoside Based Enzyme Inhibitors$73,806
S06 · FY2002 · GM
Nucleoside Based Enzyme Inhibitors$73,806
S06 · FY2002 · GM
Nucleoside Based Enzyme Inhibitors$73,806
S06 · FY2001 · GM
Nucleoside Based Enzyme Inhibitors$73,806
S06 · FY2000 · GM